Oryzon Genomics
ORY.MC
$5.18
Share price
-7.43%
Change (1 day)
49.79%
Change (1 year)
Categories
Oryzon Genomics (ORY.MC) - Cash on Hand
Cash on Hand as of September 2024 : NZ$16.43 Million
According to Oryzon Genomics's latest financial reports the company has NZ$16.43 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Oryzon Genomics - Cash on Hand chart (from 2021 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | NZ$21.42 M | -40.51% |
| 2022-12-31 | NZ$36.01 M | -24.38% |
| 2021-12-31 | NZ$47.62 M | -29.46% |
| 2020-12-31 | NZ$67.51 M | 15.6% |
| 2019-12-31 | NZ$58.4 M | -0.63% |
| 2018-12-31 | NZ$58.77 M | -1.07% |
| 2017-12-31 | NZ$59.4 M | 77.6% |
| 2016-12-31 | NZ$33.44 M | 7.56% |
| 2015-12-31 | NZ$31.09 M | 451.56% |
| 2014-12-31 | NZ$5.63 M |